Are Breast Implants Harmful? Do They Cause Cancer? FDA Report

Concerns are increasing about how safe breast silicone implants are and the complications they may cause. In response, the FDA (US Food and Drug Administration) took an important step to ensure women are fully informed about the benefits and risks of breast implants.
The published report offers labeling recommendations to manufacturers to ensure women receive information about the benefits and risks of breast implants. It includes numerous recommendations, such as including a warning and checklist in implant labeling, updating recommendations and more.
We believe women should obtain clear, up-to-date information about breast implants through discussions with their doctors. This FDA warning is an important step toward that goal.
Related topic: 5 Things to Know About Breast Implants, Cancer and Cosmetic Breast Surgery
We Do Not Know the Risks of Breast Implants
Many women appear not to be fully aware of the risks of breast implants. Women say they need more information to facilitate productive conversations with their doctors and make decisions suitable for them.
The FDA first recommends adding a boxed / bordered warning to implant labeling. A boxed warning is generally noticeable and easy to read and understand. It should help communicate risks patients may not know about.
The report recommends that manufacturers communicate specific risks in the boxed warning, including that breast implants are not lifetime devices ; the likelihood of complications increases the longer a patient has an implant, and further surgery may be needed to address complications.
Information on the maximum time breast implants can remain in the body is unclear; very few women are known to have had implants for more than 20 years.
Saline (saltwater-filled) implants have been studied over the first 10 years after implantation, with a deflation (leakage) rate of approximately 5 to 6 percent over that period. No reliable study has determined whether silicone implants leak. However, most breast implant companies recommend replacing implants every 10 years.
Breast Implants and Cancer Risk
Breast implants may pose a risk of developing large cell lymphoma (BIA-ALCL, breast implant-associated anaplastic large cell lymphoma).
For Every 100 Million Implants, 3 Cancer Cases
A boxed warning should ensure patients see this important information. In fact, this breast implant-associated large cell lymphoma risk is very low; since it was first described in 1997, only around 400 cases have been reported in the literature, and for every 100 million women, an estimated 3 new cases are diagnosed annually.
The report also recommends that implant manufacturers include a patient decision checklist at the end of the patient information booklet or brochure. This checklist can guide discussions during a consultation with a surgeon. It gives patients an opportunity to understand potential surgical risks and individual implant risks such as BIA-ALCL and implant rupture (leakage), among others.
How Should Patients with Implants Be Screened for Cancer?
This draft checklist encourages patients to ask their surgeons about experience, training and credentials. The draft guidance also proposes revisiting routine cancer screening systems for users of silicone gel-filled breast implants.
Previously, three years after breast implant surgery and every year thereafter, patients were recommended to undergo magnetic resonance (MR) imaging screening. Recommendations in the new draft advise screening patients with no signs or symptoms of implant rupture / leakage, starting 5 to 6 years after surgery and every two years thereafter, using ultrasound or MR. If a patient has symptoms at any time or inconclusive ultrasound results for implant rupture, MR is recommended.
These new screening data were revised following the American College of Radiology’s finding that rupture rates are higher five to six years after implantation. The FDA believes this descriptive information will help better inform women about the types and quantities of chemicals and heavy metals in breast implants.
Discussing Risks Increases Trust
Greater transparency about risks may also improve patient safety. In 2006, the FDA wanted manufacturers to include an information card stating the style, size and product serial number. The current report recommends including more information on the device card, including a unique device identifier. Web links in the warning box allow users easy access to updated information on the manufacturer’s website. Making this information readily accessible will help women make informed decisions with as much information as possible. This guidance is just one step taken to help women learn more about breast implants.
A meeting with breast implant manufacturers was held in the USA in early 2019 to discuss implant safety. Recently, a manufacturer was asked to recall textured breast implants because of the risk of BIA-ALCL.
In conclusion, millions of women choose breast implants each year, and this number is expected to increase. Nevertheless, they carry certain risks, albeit with very low probabilities, of which users should be aware. Implants are also not intended for lifetime use, and women with implants should be monitored periodically by magnetic resonance imaging or ultrasound for implant leakage and other risks.
*
You may be interested in: Women Receiving Breast Reconstruction with Their Own Tissue Are Happier
Sources
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.